Analysis of Neutrophil Lymphocyte Ratio and Absolute Lymphocyte Count as Predictors of Severity of COVID-19 Patients
DOI:
https://doi.org/10.24293/ijcpml.v27i2.1738Keywords:
COVID-19, neutrophil lymphocyte ratio, absolute lymphocyte count, predictorAbstract
It is important to predict the severity of COVID-19 during the pandemic. Both Neutrophil Lymphocyte Ratio (NLR) and Absolute Lymphocyte Count (ALC) are two easy, low-cost, and fast inflammatory markers, which positively correlate with the severity of COVID-19. The purpose of this research was to analyze the value of NLR and ALC as predictors of COVID-19 severity. This research was a retrospective study using medical record data of 376 COVID-19 patients during April-September 2020 at the Hasanuddin University Hospital and Makassar City Regional Hospital. Patients were classified into non-severe and severe COVID-19. Neutrophil lymphocyte ratio and ALC values were determined based on routine blood test (Sysmex XS-800i) results, statistical analysis using Independent T-test, while NLR and ALC diagnostic values were analyzed with Receiver Operating Characteristics (ROC) curve to obtain the cut-off value, p < 0.05 was significant. The samples consisted of 372 non-severe and 49 severe COVID-19 patients. Neutrophil lymphocyte ratio value in non-severe (4.02±5.22) was significantly different from severe COVID-19 (9.81±7.06) (p < 0.001), similar to ALC in non-severe (2.00±0.83x103/μL) and severe COVID-19 (1.22±0.78x103/μL) (p < 0.001). Receiver operating characteristics curve showed that NLR had a sensitivity of 91.8% and specificity of 66.4% with a cut-off ≥ 3.17 with Negative Predict Value (NPV) of 98.2% and Positive Predict Value (PPV) of 29.0%; while ALC had a sensitivity of 81.6% and specificity of 64.8% at cut-off ≤ 1.74x103/μL with NPV of 95.9% and PPV of 25.8%. Increased NLR and decreased ALC in severe COVID-19 patients occurred due to an increased inflammatory response resulting in a decreased cellular immunity. Receiver operating characteristics curve showed a cut-off for NLR of 3.17 and ALC of 1.74x103/μL, indicating an optimum sensitivity and specificity. It was concluded that NLR and ALC can be used as predictors of COVID-19 severity with a cut-off ≥ 3.17 and ≤ 1.74x103/μL, respectively.
Downloads
References
Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging
novel Coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol, 2020;
(6): 568-76.
World Health Organisation. A Coordinated global research roadmap: 2019 novel Coronavirus [Internet]. R&D Vlueprint. 2020; 65. Available from: http://dx.doi.org/10.1038/s41591-020-0935-z (accessed 3 August, 2020).
Kementrian Kesehatan. Pedoman COVID REV-4. Pedoman pencegah dan pengendali Coronavirus dis.
; 1(revisi ke-4): 1-125.
Divisi Pencegahan dan Pengendalian Infeksi Satuan Penjaminan Mutu Rumah Sakit UNHAS. Panduan
pencegahan dan pengendalian infeksi COVID-19 di RS UNHAS, 2020; 1-2.
PDPI. Panduan Praktik Klinik (PPK) Perhimpunan Dokter Paru Indonesia, 2020; 12-23.
Burhan E, Susanto AD, Nasution SA, Ginanjar E, Pitoyo CW, Susilo A, et al. Protokol pelaksanaan COVID-19. 2020; 1-50. Available from: http://inaheart.org/perki/u p l o a d / f i l e s / p r o t o k o l % 2 0 T a t a l a k s a n a % 2 0COVID-19%205OP%20FINAL(4).pdf (accessed 27 April, 2020).
COVID-19 kemenkes.go.id. Situasi terkini perkembangan Coronavirus Disease (COVID-19).
Available from https://Covid19.kemkes.go.id/situasi-infeksi-emerging/info-corona-virus/situasi-terkini
-perkembangan-coronavirus-disease-COVID-19-3-agustus-2020/#.XykMYlUzbIU (accessed 3 August,
.
Soraya GV, Ulhaq ZS. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated
meta-analysis. Med Clin (Barc), 2020; 1-25.
Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: What has been learned and to be learned about the novel Coronavirus disease?. Int J Biol Sci, 2020; 16(10): 1753-66.
Fu J, Kong J, Wang W, Wu M, Yao L, Wang Z, et al. The clinical implication of dynamic neutrophil to
lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thromb Res
[Internet]. 2020; 192: 3-8. Available from: https://doi.org/10.1016/j.thromres.2020.05.006 (accessed 5 August, 2020).
Farkas J. Neutrophil-Lymphocyte Ratio (NLR): Free upgrade to your WBC. 2019; 1-29. Available from:
http://www.emcrit.org/pulmcrit/nlr. (accessed 5 August, 2020).
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent
risk factor for mortality in hospitalized patients with COVID-19. J Infect, 2020; 17(28): 1-7.
Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with Heo JY. Clinical and epidemiological characteristics of Coronavirus disease 2019 in the early stage of outbreak. Korean J Med, 2020; 95(2): 67-73.
Huang lan, Pranata R. Lymphopenia in severe Coronavirus Disease 2019 (COVID-19): Systemic
review and meta-analysis. Journal of Intensive Care, 2020; 36(8): 1-10.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of Coronavirus disease 2019 in China. New England Journal of Medicine [Internet]. 2020; 382(18): 1708-20. Available from: http://www.nejm.org/doi/10.1056/NEJMoa2002032 (accessed 26 Sept, 2020).
Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical
illness patients with 2019 Coronavirus disease in the early stage. J Transl Med, 2020; 18: 1.
Sun S, Cai X, Wang H, He G, Lin Y, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clinica Chimica Acta. Elsevier, 2020; 507: 174-180.
Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International Immunopharmacology, 2020; 84: 106504. Available from: https://doi.org/10.1016/j.intimp.2020.106504 (accessed 9 April, 2020).
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
